Vacancy reached a new all-time high of 36.1 percent and asking rents continued to decline. But green shoots give reason for hope.
Boston Scientific’s third-quarter revenue topped $5 billion, up 20.3% year over year. Growth eased slightly from the second quarter, when sales rose more than 22%. Urology led the gains, up 28% year ...
MARLBOROUGH, Mass. (AP) — MARLBOROUGH, Mass. (AP) — Boston Scientific Corp. (BSX) on Wednesday reported third-quarter profit of $755 million. On a per-share basis, the Marlborough, Massachusetts-based ...
Jonah Kaplan is an award-winning journalist who has built a strong reputation for his balanced reporting, thoughtful interviews, and deeply researched coverage of high-impact issues affecting the ...
MAPLE GROVE, Minn. — It was a big day for one of Minnesota's biggest med tech companies. Boston Scientific held a ribbon cutting for a new biotech facility in Maple Grove on Monday. Leaders at Boston ...
Now that Amplitude Vascular Systems is ready to start selling its medical device, the company needs a place to make it. That’s a big reason why AVS has left its Seaport digs for a much larger home in ...
Boston Scientific held a ribbon cutting for a new biotech facility in Maple Grove. Secret Service finds 17 'skimming' devices in tour of San Antonio businesses Trump admin gave GOP senators secret ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Boston Scientific Corp. is ...
Boston Scientific continues to grow in Minnesota to accommodate manufacturing needs. Chimpanzee sees the sky for the first time after freedom from caged lab Trump just kneecapped the GOP’s shutdown ...
On Friday, Boston Scientific Corporation announced an agreement to acquire Nalu Medical, a medical technology company focusing on chronic pain. Boston Scientific has been an investor in Nalu Medical ...
(Reuters) -Medical device maker Boston Scientific said on Friday it will buy the remaining equity in privately held Nalu Medical for about $533 million in cash, expanding its portfolio of treatments ...